Evidence map›Paper›PMID 32549204›Full record

ArticleMolecules (Basel, Switzerland)2020

Preparation, Characterization, and In Vitro Sustained Release Profile of Resveratrol-Loaded Silica Aerogel.

Lili Qin, Yiwei He, Xinyu Zhao, Ting Zhang, Yao Qin, Ai Du

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Passive Daytime Radiative Cooling of Silica Aerogels.Nanomaterials (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lili QinSports and Health Research Center, Department of Physical Education, Tongji University, Shanghai 200092, China.
Yiwei HeSports and Health Research Center, Department of Physical Education, Tongji University, Shanghai 200092, China.
Xinyu ZhaoSports and Health Research Center, Department of Physical Education, Tongji University, Shanghai 200092, China.
Ting ZhangSchool of Physics Science and Engineering, Tongji University, Shanghai 200092, China.
Yao QinSports and Health Research Center, Department of Physical Education, Tongji University, Shanghai 200092, China.
Ai DuSchool of Physics Science and Engineering, Tongji University, Shanghai 200092, China.ORCID 0000-0002-6113-6185
Tongji University · CN

Funding

National Key Research and Development Program of China 2017YFA0204600National Natural Science Foundation of China No. 31771313
6 · The paper itself

Abstract

Silica aerogel, a kind of nanoporous material, is regarded as a desired drug carrier for its low toxicity, high specific surface area, and excellent biocompatibility. Using silica aerogel in a drug carrier may be an appropriate method to improve the performance of pure resveratrol. In this study, resveratrol-loaded silica aerogel (RSA) as a drug delivery system was prepared by the sol-gel method. Before gelling, resveratrol was added into the hydrolyzed tetraethyl orthosilicate (TEOS) ethanol solution then dispersed by stir and ultrasound. The results showed that RSA has a high loading rate of 19% with low cost and excellent biocompatibility. The SEM images showed that silica aerogel wraps up outside the resveratrol. Sustained releasing effect could be observed in RSA after 1 h, while pure resveratrol did not display this. The release of RSA lasted for over 6 h, and the release amount reached over 90% and 80% in either simulated gastric fluid (pH = 2.0) or phosphate-buffered saline (pH = 7.4) at 37 °C. Preliminary in vitro toxicity test revealed RSA to be biocompatible and stable; and when coupled with the anti-inflammatory effects of resveratrol, showed good potential for osteoarthritis treatment.

Indexed as

Delayed-Action PreparationsDrug CarriersGelsKineticsPorosityResveratrolSilica GelSilicon DioxideDelayed-Action PreparationsDrug CarriersGelsResveratrolSilica GelSilicon Dioxidecharacterizationdrug carrierrelease kineticsresveratrolsilica aerogel

Identifiers

PMID32549204
PMCPMC7355806
OpenAlexW3035410532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.